Mendor Oy-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Mendor Oy - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013428
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendor discreet which provides daily diabetes management services. Mendor also provides mendor balance which is a software application. The company’s Mendor One is a complete package which automatically connects individuals with care providers and empowers with real-time actionable insights. It caters its products to individuals and clinics and care providers. The company has presence in Espoo and Tampere. Mendor is headquartered in Espoo, Finland.

Mendor Oy – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mendor Oy, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mendor Oy, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mendor Oy, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mendor Oy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mendor Oy, Medical Devices Deals, 2011 to YTD 2017 9
Mendor Oy, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mendor Oy, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Mendor Raises US$6.4 Million In Venture Financing 11
Mendor Secures Venture Funding from Reaktor Ventures 12
Partnerships 13
Mendor Enters Into Co-Development Agreement With Novartis 13
Mendor Oy – Key Competitors 14
Mendor Oy – Key Employees 15
Mendor Oy – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Jun 21, 2016: eClinicalHealth Announces Successful Results for an Entirely Remote Online Clinical Trial 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Mendor Oy, Pharmaceuticals & Healthcare, Key Facts 2
Mendor Oy, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mendor Oy, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mendor Oy, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mendor Oy, Deals By Therapy Area, 2011 to YTD 2017 8
Mendor Oy, Medical Devices Deals, 2011 to YTD 2017 9
Mendor Oy, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mendor Raises US$6.4 Million In Venture Financing 11
Mendor Secures Venture Funding from Reaktor Ventures 12
Mendor Enters Into Co-Development Agreement With Novartis 13
Mendor Oy, Key Competitors 14
Mendor Oy, Key Employees 15

★海外企業調査レポート[Mendor Oy-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VOCO GmbH:企業の戦略的SWOT分析
    VOCO GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Scottish Power Ltd:企業の発電所・SWOT分析2018
    Scottish Power Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Kinder Morgan Inc (KMI):企業の財務・戦略的SWOT分析
    Kinder Morgan Inc (KMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ardagh Group SA:企業の戦略・SWOT・財務情報
    Ardagh Group SA - Strategy, SWOT and Corporate Finance Report Summary Ardagh Group SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • WESCO International Inc (WCC)
    WESCO International Inc (WCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Culture Landmark Investment Ltd:企業の戦略・SWOT・財務分析
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • TC Pipelines LP (TCP):石油・ガス:M&Aディール及び事業提携情報
    Summary TC Pipelines LP (TC Pipelines) is an oil and gas company that manages natural gas pipelines and related assets. The company offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • Lakes Oil NL (LKO):企業の財務・戦略的SWOT分析
    Summary Lakes Oil NL (Lake Oil) is an upstream company that carries out exploration and production oil and gas. The company acquires, explores, and develops oil and natural gas properties. It operates Gippsland basin and Otway basin in Australia. Lake Oil offers re-processing and re-mapping of avail …
  • Hypera SA:企業の戦略・SWOT・財務情報
    Hypera SA - Strategy, SWOT and Corporate Finance Report Summary Hypera SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • ComOps Limited (COM):企業の財務・戦略的SWOT分析
    ComOps Limited (COM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DCP Midstream Partners, LP:企業の戦略・SWOT・財務情報
    DCP Midstream Partners, LP - Strategy, SWOT and Corporate Finance Report Summary DCP Midstream Partners, LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Inovio Pharmaceuticals Inc (INO)-医療機器分野:企業M&A・提携分析
    Summary Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA vaccines (immunotherapies) for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology a …
  • Supernus Pharmaceuticals Inc (SUPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …
  • Smithfield Foods Inc:戦略・SWOT・企業財務分析
    Smithfield Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Smithfield Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • UTStarcom Holdings Corp. (UTSI):企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • National Gas & Industrial Co (2080):企業の財務・戦略的SWOT分析
    National Gas & Industrial Co (2080) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Rafako SA (RFK):電力:M&Aディール及び事業提携情報
    Summary Rafako SA (Rafako), a subsidiary of PBG SA is a power generation equipment manufacturer that designs and distributes boilers and environment protection units. The company provides a range of boilers such as PC boilers, circulating fluidized bed (CFB) boilers, heat recovery steam generator (H …
  • African Development Bank Group-エネルギー分野:企業M&A・提携分析
    Summary African Development Bank Group (AfDB) is a development finance institution. It promotes social and economic development by providing loans, grants, guarantees, equity investments and technical assistance in its regional member countries. The constituent institutions of the bank include The A …
  • Asahi Intecc Co Ltd (7747):企業の財務・戦略的SWOT分析
    Summary Asahi Intecc Co Ltd (Asahi) is a medical device company that develops, manufactures and markets terminal processed products. The company provides medical components such as guide wires, balloon catheters, guiding catheters, penetration catheters, peripheral guide wires, IVR guide wires and m …
  • Kansai Paint Co Ltd (4613):企業の財務・戦略的SWOT分析
    Kansai Paint Co Ltd (4613) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆